Journal of Thrombosis and Haemostasis, 1538-7933

Journal

More filtering options
  1. Prophylaxis Escalation in Severe von Willebrand Disease: A Prospective Study from the von Willebrand Disease Prophylaxis Network.

    Abshire, T., Cox-Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S. & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 9, p. 1585-1589

    Research output: Contribution to journalArticle

  2. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.

    Agersø, H., Brophy, D. F., Pelzer, H., Martin, E. J., Carr, M., Hedner, U. & Ezban, M., 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 333-338

    Research output: Contribution to journalArticle

  3. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding

    Ajzner, E., Balogh, I., Haramura, G., Boda, Z., Kalmar, K., Pfliegler, G., Björn Dahlbäck & Muszbek, L., 2003, In : Journal of Thrombosis and Haemostasis. 1, 5, p. 943-949

    Research output: Contribution to journalArticle

  4. Are randomized clinical trials the only truth? Not always

    Aledort, L., Rolf Ljung & Blanchette, V., 2006, In : Journal of Thrombosis and Haemostasis. 4, 3, p. 503-504

    Research output: Contribution to journalDebate/Note/Editorial

  5. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A

    Jan Astermark, Wang, X., Oldenburg, J., Erik Berntorp & Lefvert, A. -K., 2007, In : Journal of Thrombosis and Haemostasis. 5, 2, p. 263-265

    Research output: Contribution to journalArticle

  6. The von Willebrand disease prophylaxis network: exploring a treatment concept.

    Erik Berntorp & Abshire, T., 2006, In : Journal of Thrombosis and Haemostasis. 4, 11, p. 2511-2512

    Research output: Contribution to journalArticle

  7. Definitions in hemophilia: communication from the SSC of the ISTH

    Blanchette, V. S., Key, N. S., Rolf Ljung, Manco-Johnson, M. J., Van Den Berg, H. M. & Srivastava, A., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1935-1939

    Research output: Contribution to journalArticle

  8. Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin (R)): a prospective study of 50 patients

    Borel-Derlon, A., Federici, A. B., Roussel-Robert, V., Goudemand, J., Lee, C. A., Scharrer, I., Rothschild, C., Erik Berntorp, Henriet, C., Tellier, Z., Bridey, F. & Mannucci, P. M., 2007, In : Journal of Thrombosis and Haemostasis. 5, 6, p. 1115-1124

    Research output: Contribution to journalArticle

  9. Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: A two-center study

    Bowyer, A. E., A. Hillarp, Ezban, M., Persson, P. & Kitchen, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 7, p. 1428-1435

    Research output: Contribution to journalArticle

  10. Population Pharmacokinetics of Plasma-Derived Factor IX: Procedures for Dose Individualization.

    Brekkan, A., Erik Berntorp, Jensen, K., Nielsen, E. I. & Jönsson, S., 2016, In : Journal of Thrombosis and Haemostasis. 14, 4, p. 724-732

    Research output: Contribution to journalArticle

  11. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Budde, U., Schneppenheim, R., Eikenboom, J., Goodeve, A., Will, K., Drewke, E., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Perez, A., Meyer, D., Mazurier, C., Goudemand, J., Ingerslev, J., Habart, D., Vorlova, Z., Holmberg, L., Lethagen, S., Pasi, J. & 2 othersHill, F. & Peake, I., 2008, In : Journal of Thrombosis and Haemostasis. 6, 5, p. 762-771

    Research output: Contribution to journalArticle

  12. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

    Castaman, G., Rodeghiero, F., Tosetto, A., Cappelletti, A., Baudo, F., Eikenboom, J. C. J., Federici, A. B., Lethagen, S., Linari, S., Lusher, J., Nishino, M., Petrini, P., Srivastava, A. & Ungerstedt, J. S., 2006, In : Journal of Thrombosis and Haemostasis. 4, 10, p. 2164-2169

    Research output: Contribution to journalArticle

  13. Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

    Clark, C. A., Vatsyayan, R., Hedner, U., Esmon, C. T., Pendurthi, U. R. & Rao, L. V. M., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2383-2391

    Research output: Contribution to journalArticle

  14. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

    Collins, P. W., Blanchette, V. S., Fischer, K., Bjorkman, S., Oh, M., Fritsch, S., Schroth, P., Spotts, G., Jan Astermark & Ewenstein, B., 2009, In : Journal of Thrombosis and Haemostasis. 7, 3, p. 413-420

    Research output: Contribution to journalArticle

  15. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.

    Collins, P. W., Møss, J., Knobe, K., Groth, A., Colberg, T. & Watson, E., 2012, In : Journal of Thrombosis and Haemostasis. 10, 11, p. 2305-2312

    Research output: Contribution to journalArticle

  16. The discovery of activated protein C resistance.

    Björn Dahlbäck, 2003, In : Journal of Thrombosis and Haemostasis. 1, 1, p. 3-9

    Research output: Contribution to journalArticle

  17. Molecular recognition in the protein C anticoagulant pathway.

    Björn Dahlbäck & Villoutreix, B. O., 2003, In : Journal of Thrombosis and Haemostasis. 1, 7, p. 1525-1534

    Research output: Contribution to journalArticle

  18. The multiple faces of the partial thromboplastin time APTT.

    Björn Dahlbäck, 2004, In : Journal of Thrombosis and Haemostasis. 2, 12, p. 2256-2257

    Research output: Contribution to journalLetter

  19. The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A

    Eckhardt, C. L., Jan Astermark, Nagelkerke, S. Q., Geissler, J., Tanck, M. W. T., Peters, M., Fijnvandraat, K. & Kuijpers, T. W., 2014, In : Journal of Thrombosis and Haemostasis. 12, 8, p. 1294-1301

    Research output: Contribution to journalArticle

  20. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal

    Egberg, N., Fagerberg, I., Andreas Hillarp, Lindahl, TL. & Stigendal, L., 2005, In : Journal of Thrombosis and Haemostasis. 3, 10, p. 2370-2371

    Research output: Contribution to journalLetter

  21. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

    Eikenboom, J., Van Marion, V., Putter, H., Goodeve, A., Rodeghiero, F., Castaman, G., Federici, AB., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Schneppenheim, R., Budde, U., Ingerslev, J., Vorlova, Z., Habart, D., Holmberg, L., Lethagen, S., Pasi, J., Hill, F. & 1 othersPeake, I., 2006, In : Journal of Thrombosis and Haemostasis. 4, 4, p. 774-782

    Research output: Contribution to journalArticle

  22. Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.

    Carl Ekman, Stenhoff, J. & Björn Dahlbäck, 2010, In : Journal of Thrombosis and Haemostasis. 8, 4, p. 838-844

    Research output: Contribution to journalArticle

  23. Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies

    Eliasson, A., Bergqvist, D., Bjorck, M., Stefan Acosta, Sternby, N. & Ogren, M., 2006, In : Journal of Thrombosis and Haemostasis. 4, 9, p. 1897-1902

    Research output: Contribution to journalArticle

  24. Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)

    Gopalakrishnan, R., Hedner, U., Ghosh, S., Nayak, R. C., Allen, T. C., Pendurthi, U. R. & Rao, L. V. M., 2010, In : Journal of Thrombosis and Haemostasis. 8, 2, p. 301-310

    Research output: Contribution to journalArticle

  25. rFVIIa transported from the blood stream into tissues is functionally active

    Gopalakrishnan, R., Hedner, U., Clark, C., Pendurthi, U. R. & Rao, L. V. M., 2010, In : Journal of Thrombosis and Haemostasis. 8, 10, p. 2318-2321

    Research output: Contribution to journalLetter

  26. Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa.

    Gopalakrishnan, R., Pendurthi, U. R., Hedner, U., Agersø, H., Esmon, C. T. & Rao, L. V. M., 2012, In : Journal of Thrombosis and Haemostasis. 10, 5, p. 971-973

    Research output: Contribution to journalLetter

  27. Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

    Goudemand, J., Scharrer, I., Erik Berntorp, Lee, CA., Borel-Derlon, A., Stieltjes, N., Caron, C., Scherrmann, JM., Bridey, F., Tellier, Z., Federici, AB. & Mannucci, PM., 2005, In : Journal of Thrombosis and Haemostasis. 3, 10, p. 2219-2227

    Research output: Contribution to journalArticle

  28. A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).

    Gringeri, A., Björn Lundin, Mackensen, S. V., Mantovani, L. & Mannucci, P. M., 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 700-710

    Research output: Contribution to journalArticle

  29. Origin of Swedish hemophilia B mutations

    Hallden, C., Annika Mårtensson, Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2013, In : Journal of Thrombosis and Haemostasis. 11, 11, p. 2001-2008

    Research output: Contribution to journalArticle

  30. Origin of Swedish hemophilia A mutations

    Halldén, C., Nilsson, D., Torbjörn Säll, Lind-Hallden, C., Liden, A. C. & Rolf Ljung, 2012, In : Journal of Thrombosis and Haemostasis. 10, 12, p. 2503-2511

    Research output: Contribution to journalArticle

  31. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with haemophilia A and B.

    Hansson, K. M., Gustafsson, D., Skärby, T., Frison, L. & Erik Berntorp, 2015, In : Journal of Thrombosis and Haemostasis. 13, 7, p. 1293-1300

    Research output: Contribution to journalArticle

  32. Post-translational modifications in proteins involved in blood coagulation.

    Hansson, K. M. & Johan Stenflo, 2005, In : Journal of Thrombosis and Haemostasis. 3, 12, p. 2633-2648

    Research output: Contribution to journalReview article

  33. The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX

    He, S., Blomback, M., Ekman, GJ. & Hedner, U., 2003, In : Journal of Thrombosis and Haemostasis. 1, 6, p. 1215-1219

    Research output: Contribution to journalArticle

  34. Potential role of rFVIIa in prophylaxis in severe haemophilia patients with inhibitors.

    Hedner, U., 2006, In : Journal of Thrombosis and Haemostasis. 4, Aug 14, p. 2498-2500

    Research output: Contribution to journalArticle

  35. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?

    Hermans, C., Jan Astermark & De Moerloos, P., 2012, In : Journal of Thrombosis and Haemostasis. 10, 10, p. 2194-2196

    Research output: Contribution to journalLetter

  36. Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.

    Andreas Hillarp, Gustafsson, K. M., Faxälv, L., Strandberg, K., Baghaei, F., Fagerberg Blixter, I., Berndtsson, M. & Lindahl, T. L., 2014, In : Journal of Thrombosis and Haemostasis. 12, 9, p. 1545-1553

    Research output: Contribution to journalArticle

  37. Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity.

    Andreas Hillarp, Lethagen, S. & Mattiasson, I., 2003, In : Journal of Thrombosis and Haemostasis. 1, 1, p. 196-197

    Research output: Contribution to journalLetter

  38. Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol.

    Andreas Hillarp, Stadler, M., Haderer, C., Weinberger, J., Kessler, C. M. & Römisch, J., 2010, In : Journal of Thrombosis and Haemostasis. 8, p. 2216-2223

    Research output: Contribution to journalArticle

  39. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.

    Andreas Hillarp, Baghaei, F., Blixter, I. F., Gustafsson, K. M., Stigendal, L., Sten-Linder, M., Strandberg, K. & Lindahl, T. L., 2011, In : Journal of Thrombosis and Haemostasis. 9, p. 133-139

    Research output: Contribution to journalArticle

  40. Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.

    Högberg, C., Olof Gidlöf, Tan, C., Svensson, S., Öhman, J., David Erlinge & Björn Olde, 2011, In : Journal of Thrombosis and Haemostasis. 9, 2, p. 361-372

    Research output: Contribution to journalArticle

  41. Desmopressin (DDAVP) and factor VIII

    Lars Holmberg, 2003, In : Journal of Thrombosis and Haemostasis. 1, 9, p. 2046-2047

    Research output: Contribution to journalDebate/Note/Editorial

  42. Elevated risk of venous but not arterial thrombosis in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma

    Hultcrantz, M., Pfeiffer, R. M., Bjorkholm, M., Goldin, L. R., Ingemar Turesson, Schulman, S., Landgren, O. & Kristinsson, S. Y., 2014, In : Journal of Thrombosis and Haemostasis. 12, 11, p. 1816-1821

    Research output: Contribution to journalArticle

  43. Fresh frozen plasma reduces thrombin formation in newborn infants

    Hyytiainen, S., Syrjala, M., Vineta Fellman, Heikinheimo, M. & Petaja, J., 2003, In : Journal of Thrombosis and Haemostasis. 1, 6, p. 1189-1194

    Research output: Contribution to journalArticle

  44. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice

    Annika Jögi, Pass, J., Hoyer-Hansen, G., Lund, L. R., Nielsen, B. S., Dano, K. & Romer, J., 2007, In : Journal of Thrombosis and Haemostasis. 5, 9, p. 1936-1944

    Research output: Contribution to journalArticle

Previous 1 2 3 Next